In JOINT-STOCK COMPANY "R-FARM" excluded carrying out IPO in 2023

@Farmatsevticheskij vestnik
#Entrepreneurship#Finances & Markets
Show original
Company explained it with lack of optimum conditions on...
Full text at the source
Analysis
×
Quotes
All Quotes
The plant will make preparations for treatment of oncological diseases, hematologic, diseases of respiratory organs and autoimmune diseases. Generally it is an import-substituting portfolio of preparations
Vasilii Ignatyev8/21/2023
People
Person ranking
Vasilii Ignatyev
Last position: CEO (LLC "R2MED")
2
Vladimir Petrovich Yevtushenkov
Last position: The member of Bureau of Board, the Chairman of the Committee on industrial policy (RSPP)
2
Organizations
Organization Ranking
157
PJSFC Sistema
Main activity:Finance
157
32
JOINT-STOCK COMPANY "R-FARM"
Main activity:Health care and social services
32
11
JOINT-STOCK COMPANY "BINNOFARM"
Main activity:Health care and social services
11